These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 30248656)

  • 1. Piperidylthiosemicarbazones Cu(II) complexes with a high anticancer activity by catalyzing hydrogen peroxide to degrade DNA and promote apoptosis.
    Qi J; Yao Q; Tian L; Wang Y
    Eur J Med Chem; 2018 Oct; 158():853-862. PubMed ID: 30248656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands.
    Deng J; Yu P; Zhang Z; Wang J; Cai J; Wu N; Sun H; Liang H; Yang F
    Eur J Med Chem; 2018 Oct; 158():442-452. PubMed ID: 30241011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents.
    Gou Y; Li J; Fan B; Xu B; Zhou M; Yang F
    Eur J Med Chem; 2017 Jul; 134():207-217. PubMed ID: 28415010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer potency of copper(II) complexes of thiosemicarbazones.
    Singh NK; Kumbhar AA; Pokharel YR; Yadav PN
    J Inorg Biochem; 2020 Sep; 210():111134. PubMed ID: 32673842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
    Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
    J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes.
    Anjum R; Palanimuthu D; Kalinowski DS; Lewis W; Park KC; Kovacevic Z; Khan IU; Richardson DR
    Inorg Chem; 2019 Oct; 58(20):13709-13723. PubMed ID: 31339305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cu/ligand stoichiometry effect on the coordination behavior of aroyl hydrazone with copper(II): Structure, anticancer activity and anticancer mechanism.
    Deng J; Gou Y; Chen W; Fu X; Deng H
    Bioorg Med Chem; 2016 May; 24(10):2190-8. PubMed ID: 27056799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).
    Qin QP; Liu YC; Wang HL; Qin JL; Cheng FJ; Tang SF; Liang H
    Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
    Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cu(ii)-TACN complexes selectively induce antitumor activity in HepG-2 cells via DNA damage and mitochondrial-ROS-mediated apoptosis.
    Liu M; Song XQ; Wu YD; Qian J; Xu JY
    Dalton Trans; 2020 Jan; 49(1):114-123. PubMed ID: 31793575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of the Impact of Copper(II) α-(N)-Heterocyclic Thiosemicarbazone Complexes on DNA Topoisomerase IIα.
    Wilson JT; Jiang X; McGill BC; Lisic EC; Deweese JE
    Chem Res Toxicol; 2016 Apr; 29(4):649-58. PubMed ID: 26982206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first copper(I) complex of anthrahydrazone with potential ROS scavenging activity showed significant in vitro anticancer activity by inducing apoptosis and autophagy.
    Liu RX; Luo RY; Tang MT; Liu YC; Chen ZF; Liang H
    J Inorg Biochem; 2021 May; 218():111390. PubMed ID: 33721719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands.
    Rogolino D; Cavazzoni A; Gatti A; Tegoni M; Pelosi G; Verdolino V; Fumarola C; Cretella D; Petronini PG; Carcelli M
    Eur J Med Chem; 2017 Mar; 128():140-153. PubMed ID: 28182987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiosemicarbazone N-Heterocyclic Cu(II) complexes inducing nuclei DNA and mitochondria damage in hepatocellular carcinoma cells.
    Zhang S; Zhao J; Guo Y; Hu J; Chen X; Ruan H; Cao T; Hou H
    J Inorg Biochem; 2022 Nov; 236():111964. PubMed ID: 36027842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octahedral copper(ii)-diimine complexes of triethylenetetramine: effect of stereochemical fluxionality and ligand hydrophobicity on Cu
    Sharma M; Ganeshpandian M; Majumder M; Tamilarasan A; Sharma M; Mukhopadhyay R; Islam NS; Palaniandavar M
    Dalton Trans; 2020 Jun; 49(24):8282-8297. PubMed ID: 32510543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Complexation of Thiosemicarbazone Derivatives with Cu (II) Ions on Their Antitumor Activity against Melanoma Cells.
    Pitucha M; Korga-Plewko A; Czylkowska A; Rogalewicz B; Drozd M; Iwan M; Kubik J; Humeniuk E; Adamczuk G; Karczmarzyk Z; Fornal E; Wysocki W; Bartnik P
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of the structure and antitumor mechanism of mononuclear and trinucleated thiosemicarbazone Cu(II) complexes.
    Zheng Y; Wei K; Gao Y; Zhou Z; Zheng X; Li J; Qi J
    J Inorg Biochem; 2023 Mar; 240():112116. PubMed ID: 36592511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiosemicarbazone(s)-anchored water soluble mono- and bimetallic Cu(ii) complexes: enzyme-like activities, biomolecular interactions, anticancer property and real-time live cytotoxicity.
    Balakrishnan N; Haribabu J; Dhanabalan AK; Swaminathan S; Sun S; Dibwe DF; Bhuvanesh N; Awale S; Karvembu R
    Dalton Trans; 2020 Jul; 49(27):9411-9424. PubMed ID: 32589180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1
    Cai DH; Chen BH; Liu QY; Le XY; He L
    Dalton Trans; 2022 Nov; 51(43):16574-16586. PubMed ID: 36263706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, crystal structure, DNA interaction and anticancer activity of tridentate copper(II) complexes.
    Li GY; Du KJ; Wang JQ; Liang JW; Kou JF; Hou XJ; Ji LN; Chao H
    J Inorg Biochem; 2013 Feb; 119():43-53. PubMed ID: 23186647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.